Trevi Therapeutics (TRVI) Short Interest Ratio & Short Volume $4.60 -0.20 (-4.17%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$4.43 -0.17 (-3.59%) As of 02/21/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Trevi Therapeutics Short Interest DataTrevi Therapeutics (TRVI) has a short interest of 4.59 million shares. This marks a 11.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 644,860 shares to cover all short positions.Current Short Interest4,590,000 sharesPrevious Short Interest4,130,000 sharesChange Vs. Previous Month+11.14%Dollar Volume Sold Short$18.08 millionShort Interest Ratio2.7 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares76,870,000 sharesPercentage of Shares Shorted5.97%Today's Trading Volume1,897,086 sharesAverage Trading Volume644,860 sharesToday's Volume Vs. Average294% Short Selling Trevi Therapeutics? Sign up to receive the latest short interest report for Trevi Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRVI Short Interest Over TimeTRVI Days to Cover Over TimeTRVI Percentage of Float Shorted Over Time Trevi Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20254,590,000 shares $18.08 million +11.1%N/A2.7 $3.94 1/15/20254,130,000 shares $15.78 million +6.7%N/A2.4 $3.82 12/31/20243,870,000 shares $15.94 million -17.0%N/A2.3 $4.12 12/15/20244,660,000 shares $19.43 million +230.5%N/A2.8 $4.17 11/30/20241,410,000 shares $4.06 million -19.4%N/A2.8 $2.88 11/15/20241,750,000 shares $4.81 million +1.7%N/A3.7 $2.75 10/31/20241,720,000 shares $5.07 million +13.2%N/A4.4 $2.95 10/15/20241,520,000 shares $4.83 million +0.7%N/A4.6 $3.18 9/30/20241,510,000 shares $5.04 million +8.6%N/A5.7 $3.34 9/15/20241,390,000 shares $4.68 million -10.3%N/A5.4 $3.37 Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,550,000 shares $4.90 million +3.3%N/A6.8 $3.16 8/15/20241,500,000 shares $4.13 million +16.3%N/A6.6 $2.75 7/31/20241,290,000 shares $4.10 million +1.6%N/A5.6 $3.18 7/15/20241,270,000 shares $3.62 million +32.6%N/A5.6 $2.85 6/30/2024957,600 shares $2.85 million -0.4%N/A4.4 $2.98 6/15/2024961,000 shares $2.55 million +13.1%N/A4.8 $2.65 5/31/2024849,600 shares $2.18 million -13.9%N/A4 $2.57 5/15/2024986,400 shares $2.73 million -6.1%N/A4.2 $2.77 4/30/20241,050,000 shares $3.08 million +16.9%N/A3.6 $2.93 4/15/2024898,400 shares $2.52 million -13.6%N/A3 $2.81 3/31/20241,040,000 shares $3.59 million -2.8%N/A3.5 $3.45 3/15/20241,070,000 shares $3.58 million -13.7%N/A3.8 $3.35 2/29/20241,240,000 shares $3.62 million +4.2%N/A4.2 $2.92 2/15/20241,190,000 shares $2.83 million -13.8%N/A2.7 $2.38 1/31/20241,380,000 shares $1.96 million +11.3%N/A3.6 $1.42 1/15/20241,240,000 shares $1.76 million +6.0%N/A3.2 $1.42 12/31/20231,170,000 shares $1.57 million +15.8%N/A3.1 $1.34 12/15/20231,010,000 shares $1.29 million -7.3%N/A2.8 $1.28 11/30/20231,090,000 shares $1.23 million -4.4%N/A3.4 $1.13 11/15/20231,140,000 shares $1.57 million -1.7%N/A6.4 $1.38 10/31/20231,160,000 shares $2.06 million -4.9%N/A14 $1.78 10/15/20231,220,000 shares $2.48 million -3.2%N/A18.8 $2.03 9/30/20231,260,000 shares $2.75 million -4.6%N/A17.5 $2.18 9/15/20231,320,000 shares $3.10 million +0.8%N/A14.1 $2.35 8/31/20231,310,000 shares $2.90 million -3.7%N/A6.5 $2.21 8/15/20231,360,000 shares $3.29 million +3.0%N/A4.1 $2.42 7/31/20231,320,000 shares $3.14 million +1.5%N/A3.6 $2.38 7/15/20231,300,000 shares $2.81 million -2.3%N/A3.3 $2.16 6/30/20231,330,000 shares $3.18 million +482.8%N/A3.5 $2.39 6/15/2023228,200 shares $588,756.00 -5.9%N/A0.6 $2.58Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 5/31/2023242,600 shares $524,016.00 -2.1%N/A1 $2.16 5/15/2023247,900 shares $654,456.00 -11.6%N/A1.5 $2.64 4/30/2023280,300 shares $964,232.00 +39.2%N/A3.4 $3.44 4/15/2023201,300 shares $380,457.00 +15.4%N/A3.2 $1.89 3/31/2023174,400 shares $322,640.00 +51.9%N/A3.6 $1.85 3/15/2023114,800 shares $210,084.00 +73.2%N/A1.1 $1.83 2/28/202366,300 shares $158,457.00 -15.8%N/A0.6 $2.39 2/15/202378,700 shares $201,472.00 -11.6%N/A0.7 $2.56 1/31/202389,000 shares $207,370.00 -7.0%N/A0.8 $2.33 1/15/202395,700 shares $250,734.00 +0.8%N/A0.8 $2.62 12/30/202294,900 shares $183,157.00 -40.6%N/A0.7 $1.93 12/15/2022159,800 shares $356,354.00 -34.2%N/A0.8 $2.23 11/30/2022242,800 shares $456,464.00 -16.3%N/A1.2 $1.88 11/15/2022289,900 shares $637,780.00 -1.9%N/A1.2 $2.20 10/31/2022295,600 shares $585,288.00 -27.0%N/A1.1 $1.98 10/15/2022405,100 shares $725,129.00 +264.0%N/A1.3 $1.79 9/30/2022111,300 shares $171,402.00 +12.5%N/A0.3 $1.54 9/15/202298,900 shares $306,590.00 -9.9%N/A0.1 $3.10 8/31/2022109,700 shares $348,846.00 -2.3%0.6%0.1 $3.18 8/15/2022112,300 shares $424,494.00 -19.1%0.6%0.1 $3.78 7/31/2022138,800 shares $424,728.00 -29.9%1.1%0.1 $3.06 7/15/2022198,100 shares $691,369.00 +99.3%1.5%0.1 $3.49 6/30/202299,400 shares $279,314.00 +10.3%0.8%0.1 $2.81 6/15/202290,100 shares $199,121.00 -29.7%0.8%0.1 $2.21 5/31/2022128,100 shares $310,002.00 -48.5%1.1%0.2 $2.42 5/15/2022248,800 shares $549,848.00 -37.4%2.2%0.2 $2.21 4/30/2022397,500 shares $1.07 million -27.6%11.7%0.3 $2.70 4/15/2022548,900 shares $1.80 million +66.6%3.9%0.5 $3.28 3/31/2022329,400 shares $724,680.00 -60.4%2.3%0.3 $2.20 3/15/2022832,300 shares $1.22 million +40.9%N/A1.3 $1.46 2/28/2022590,800 shares $378,112.00 +286.9%4.5%1 $0.64 2/15/2022152,700 shares $79,251.30 +95.5%1.2%0.6 $0.52 1/31/202278,100 shares $49,804.37 +4.3%0.8%0.3 $0.64 1/15/202274,900 shares $53,830.63 -34.9%0.8%0.3 $0.72 12/31/2021115,100 shares $90,031.22 +16.6%1.2%0.2 $0.78 12/15/202198,700 shares $70,767.90 +16.7%1.0%0.2 $0.72 11/30/202184,600 shares $84,143.16 -42.2%1.2%0.2 $0.99 11/15/2021146,400 shares $161,040.00 -8.3%2.1%0.3 $1.10 10/29/2021159,700 shares $187,647.50 +14.3%2.8%0.4 $1.18 10/15/2021139,700 shares $180,213.00 +25.9%2.4%0.4 $1.29 9/30/2021111,000 shares $155,400.00 +26.1%1.5%0.4 $1.40 9/15/202188,000 shares $123,200.00 +43.1%1.2%1.5 $1.40 8/31/202161,500 shares $102,090.00 -23.8%0.8%0.8 $1.66 8/13/202180,700 shares $162,610.50 +11.3%1.1%1.2 $2.02 7/30/202172,500 shares $137,750.00 -28.0%1.1%1.1 $1.90 7/15/2021100,700 shares $196,365.00 +16.7%1.6%1.4 $1.95 6/30/202186,300 shares $194,175.00 -1.9%1.3%1.3 $2.25 6/15/202188,000 shares $196,240.00 -6.1%1.5%1.5 $2.23 5/28/202193,700 shares $199,581.00 +11.7%1.6%2.5 $2.13 5/14/202183,900 shares $168,639.00 +36.0%1.4%1.8 $2.01Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 4/30/202161,700 shares $144,995.00 -30.6%1.0%1 $2.35 4/15/202188,900 shares $221,805.50 +31.7%1.5%1 $2.50 3/31/202167,500 shares $193,050.00 -46.5%1.4%0.7 $2.86 3/15/2021126,200 shares $340,740.00 +132.4%2.9%1.1 $2.70 2/26/202154,300 shares $155,298.00 -16.3%1.2%0.5 $2.86 2/12/202164,900 shares $205,733.00 +2.0%1.5%0.6 $3.17 1/29/202163,600 shares $192,708.00 +35.6%1.5%0.7 $3.03 1/15/202146,900 shares $140,700.00 +4.9%1.1%0.7 $3.00 12/31/202044,700 shares $113,538.00 -0.9%1.0%1 $2.54 12/15/202045,100 shares $132,143.00 +14.5%1.1%1.3 $2.93 11/30/202039,400 shares $121,549.00 -12.4%0.9%1.7 $3.09 11/15/202045,000 shares $151,200.00 -5.9%1.6%1.6 $3.36 10/30/202047,800 shares $152,004.00 +13.8%1.7%1.1 $3.18 10/15/202042,000 shares $153,300.00 -40.8%1.5%0.5 $3.65 9/30/202070,900 shares $285,727.00 -9.6%2.5%0.8 $4.03 9/15/202078,400 shares $301,840.00 +185.1%2.7%0.8 $3.85 8/31/202027,500 shares $110,825.00 -67.1%1.0%0.3 $4.03 8/14/202083,700 shares $490,482.00 +65.7%3.3%0.6 $5.86 7/31/202050,500 shares $250,985.00 +18.5%1.9%0.4 $4.97 7/15/202042,600 shares $218,964.00 -29.9%1.6%0.5 $5.14 6/30/202060,800 shares $417,696.00 +1.8%2.4%0.7 $6.87 6/15/202059,700 shares $271,038.00 +7,362.5%2.3%0.5 $4.54 5/29/2020800 shares $2,216.00 -97.1%0.0%0 $2.77 5/15/202027,800 shares $77,840.00 +1.5%1.1%0.4 $2.80 4/30/202027,400 shares $78,364.00 +1,342.1%1.1%0.4 $2.86 4/15/20201,900 shares $5,424.50 -77.9%0.1%0 $2.86 3/31/20208,600 shares $24,768.00 +126.3%0.3%0.1 $2.88 3/13/20203,800 shares $10,260.00 +18.8%0.2%1.8 $2.70 2/28/20203,200 shares $7,552.00 -13.5%0.1%0.4 $2.36 TRVI Short Interest - Frequently Asked Questions What is Trevi Therapeutics' current short interest? Short interest is the volume of Trevi Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 4,590,000 shares of TRVI short. Learn More on Trevi Therapeutics' current short interest. What is a good short interest ratio for Trevi Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRVI shares currently have a short interest ratio of 3.0. Learn More on Trevi Therapeutics's short interest ratio. Which institutional investors are shorting Trevi Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Trevi Therapeutics: J. Goldman & Co LP, Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Trevi Therapeutics' short interest increasing or decreasing? Trevi Therapeutics saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 4,590,000 shares, an increase of 11.1% from the previous total of 4,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Trevi Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trevi Therapeutics: Day One Biopharmaceuticals, Inc. (23.80%), Calliditas Therapeutics AB (publ) (0.01%), Xencor, Inc. (7.52%), Spyre Therapeutics, Inc. (20.50%), 89bio, Inc. (7.86%), Ocular Therapeutix, Inc. (6.91%), Arcus Biosciences, Inc. (13.05%), ARS Pharmaceuticals, Inc. (29.05%), Aurinia Pharmaceuticals Inc. (6.56%), Adaptive Biotechnologies Co. (5.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Trevi Therapeutics stock? Short selling TRVI is an investing strategy that aims to generate trading profit from Trevi Therapeutics as its price is falling. TRVI shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trevi Therapeutics? A short squeeze for Trevi Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRVI, which in turn drives the price of the stock up even further. How often is Trevi Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRVI, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies DAWN Short Interest Data CALT Short Interest Data XNCR Short Interest Data SYRE Short Interest Data ETNB Short Interest Data OCUL Short Interest Data RCUS Short Interest Data SPRY Short Interest Data AUPH Short Interest Data ADPT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRVI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRVI Stock Alerts